Autoadjusting-CPAP effect on serum Leptin concentrations in Obstructive Sleep Apnoea patients

被引：22
作者：
Drummond M. [1 ]
Winck J.C. [1 ]
Guimarães J.T. [2 ]
Santos A.C. [3 ]
Almeida J. [1 ]
Marques J.A. [1 ]
机构：
[1] Pulmonology Department, Hospital de São João, Alameda Hernâni Monteiro
[2] Clinical Pathology Department and Biochemistry, Department Hospital de São João, Alameda Hernâni Monteiro
[3] Epidemiology Department, Hospital de São João, Alameda Hernâni Monteiro
来源：
BMC Pulmonary Medicine | / 8卷 / 1期
关键词：
Obstructive Sleep Apnoea; Intermittent Hypoxia; Respiratory Disturbance Index; Obstructive Sleep Apnoea Patient; Obstructive Sleep Apnoea Severity;
D O I：
10.1186/1471-2466-8-21
中图分类号：
学科分类号：
摘要：
Background: Leptin is an hormone that regulates body weight. Studies have shown increasing leptin concentrations according to body mass index (BMI) and intermittent hypoxia. Our aim is to evaluate the basal leptin levels in OSA patients and its possible relation to OSA severity, independently of confounders and investigate the Autoadjusting-CPAP effect on leptin values. Methods: Inninety eight male patients with moderate to severe OSA leptin serum levels were evaluated before therapy, 9 days and 6 months after therapy. Results: In this group mean age was 55.3 years, mean BMI was 33.2 Kg/m2 and mean Apnoea- Hypopnea Index (AHI) was 51.7/h. Mean basal serum leptin value was 12.1 ug/L. Univariate analysis showed a significant correlation between serum leptin values and BMI (R = 0.68; p < 0.001), waist-hip ratio (R = 0.283; p = 0.004) and AHI (R = 0.198; p = 0.048); in stepwise multiple regression analysis only BMI (p < 0.001) was a predictor of serum leptin values. One week after therapy, mean leptin serum level decreased to 11.0 ug/L and 6 months after it was 11.4 ug/L. (p = 0.56 and p = 0.387, respectively) Conclusion: Baseline leptin serum levels positively correlate with BMI, fat distributioand OSA severity. BMI is the only predictor of basal leptin levels. Treatment with Autoadjusting-CPAP has a small effect on leptin levels. © 2008 Drummond et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 57 条
  • [1] Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S., The occurrence of Sleep-Disordered Breathing among middle-aged adults, N Engl J Med, 328, pp. 1230-1235, (1993)
  • [2] Vgontzas N.A., Tan T.L., Bixler E.O., Martin L.F., Shubert D., Kales A., Sleep apnea and sleep disruption in obese patients, Arch Intern Med, 154, pp. 1705-1711, (1994)
  • [3] Young T., Shahar E., Nieto F.J., Redline S., Newman A.B., Gottlieb D.J., Walsleben J.A., Finn L., Enright P., Samet J.M., Predictors of sleep-disordered breathing in community-dwelling adults, Arch Intern Med, 162, 8, pp. 893-900, (2002)
  • [4] van Boxem T.J.M., de Groot G.H., Prevalence and severity of sleep disordered breathing in a group of morbidly obese patients, Neth J Med, 54, 5, pp. 202-206, (1999)
  • [5] Richman R.M., Elliott L.M., Burns C.M., Bearpark H.M., Steinbeck K.S., Caterson I.D., The prevalence of obstructive sleep apnoea in an obese female population, Int J Obes Relat Metab Disord, 18, 3, pp. 173-177, (1994)
  • [6] Resta O., Foschino-Barbaro M.P., Legari G., Talamo S., Bonfitto P., Palumbo A., Minenna A., Giorgino R., Pergola G.D., Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects, Int J Obes Relat Metab Disord, 25, pp. 669-675, (2001)
  • [7] Malhotra A., White D., Obstructive sleep apnoea, Lancet, 360, 9328, pp. 237-245, (2002)
  • [8] Gami A.S., Caples S.M., Somers V.K., Obesity and obstructive sleep apnea, Endocrinol Metab Clin N Am, 32, pp. 869-894, (2003)
  • [9] Haynes W.G., Morgan D.A., Walsh S.A., Mark A.L., Sivitz W.I., Receptor-mediated regional sympathetic nerve activation by leptin, J Clin Invest, 100, pp. 270-278, (1997)
  • [10] Lima J., Leptin and neuroendocrinology, Arqui Med, 16, 2, pp. 115-120, (2002)
123456